n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Sarcopenia in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, T | 1 |
| Qiao, X | 1 |
| Sun, C | 1 |
| Chu, B | 1 |
| Meng, J | 1 |
| Chen, C | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Sarcopenia
| Article | Year |
|---|---|
GAPDH S-nitrosation contributes to age-related sarcopenia through mediating apoptosis.
Topics: Aging; Amidines; Animals; Apoptosis; Benzylamines; Cell Nucleus; Enzyme Inhibitors; Glyceraldehyde-3 | 2022 |